Boteng Co., Ltd. announced that in order to explore opportunities in the consumer health products market, the company plans to establish a wholly-owned subsidiary, Chongqing Yaochu Biotechnology Co., Ltd., with its own capital of RMB 30 million. The investment method is monetary investment, and the investment ratio is 100.00%.

Disclaimer:Webull uses external vendor Google Translation Service for news translations where we endeavour to ensure these are correct, however, we recommend that you please double-check this information accordingly. Webull is not responsible for translation errors or issues.